HS

Harwant Singh

Active Director Designated Partner DIN 07539062
DIN 07539062 First appointment Jul 2016 Primary industry Electrnoics
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2016
Shareholding value β€’β€’β€’β€’ Premium profile

About Harwant Singh

Data last updated:

Harwant Singh is a Designated Partner at S.B.S.N.D. Pharmaceuticals Llp (since 2016). The company operates in Electrnoics.

DIN 07539062
Primary Designation Designated Partner
Industry Electrnoics
First Appointment 25 Jul 2016
Oldest Company Age 10 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner25 Jul 20162016Active

Board colleagues of Harwant Singh

NameDINCompanyDesignation
Harminder Singh07539053S.B.S.N.D. Pharmaceuticals LlpDesignated Partner
Sarabjit Dhillon Singh07539085S.B.S.N.D. Pharmaceuticals LlpDesignated Partner

Directorship timeline

Open interactive timeline →
S.B.S.N.D. Pharmaceuticals Llp
Premium access

Shareholding and investment profile for Harwant Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Harwant Singh

Harwant Singh currently holds 1 directorship: S.B.S.N.D. Pharmaceuticals Llp (Designated Partner, since 25 Jul 2016).

Harwant Singh was first appointed on 25 Jul 2016 as Designated Partner at S.B.S.N.D. Pharmaceuticals Llp.

The current boards of Harwant Singh's companies include Harminder Singh (S.B.S.N.D. Pharmaceuticals Llp), Sarabjit Dhillon Singh (S.B.S.N.D. Pharmaceuticals Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available